Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Rezolute Reports First Quarter Fiscal 2027 Financial Results and Provides Business Update
GlobeNewswire, Inc.
REDWOOD CITY, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (Rezolute or the Company), a late-stage ultra-rare, metabolic disease company focused on treating refractory hypoglycemia caused by any form of hyperinsulinism...
Celldex Reports Third Quarter Financial Results and Provides Corporate Update
GlobeNewswire, Inc.
Best-in-disease results from Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 studies showed rapid, profound, sustained efficacy supporting barzolvolimab’s potential to be a transformational therapy in CSU BLA submission for barzolvolimab in CSU anticipated in...
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2026 Financial Results
GlobeNewswire, Inc.
Enrollment in soquelitinib registrational Phase 3 relapsed/refractory peripheral T-cell lymphoma (PTCL) and Phase 2 atopic dermatitis trials on track Angel Pharmaceuticals completes enrollment in cohort 1 of Phase 1b/2 atopic dermatitis trial;...
LB Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire, Inc.
Strengthened leadership with the appointment of Susan G. Kozauer, M.D., as Chief Medical Officer and Joseph Miller as Chief Financial Officer On track for topline data readout from the pivotal Phase 3 NOVA-2 trial of LB-102 in schizophrenia in 1H...
ARS Pharma Reports Business Highlights and Third Quarter 2026 Financial Results
GlobeNewswire, Inc.
Total Q3 revenue of $37.7 million, including $33.4 million in U.S. net product revenue for neffy® neffy U.S. market share reached 5% overall and 9% in field-targeted accounts, supporting the company’s updated targeted provider commercial strategy...
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2026 Financial Results
GlobeNewswire, Inc.
Preparing for anticipated bezuclastinib launch in GIST; PDUFA action date November 30, 2026 NonAdvSM PDUFA target action date December 30, 2026; AdvSM PDUFA target action date June 29, 2027 Cash balance of $791.1 million expected to fund...
CAMP4 Reports Third Quarter 2026 Financial Results and Corporate Highlights
GlobeNewswire, Inc.
Received authorization in the United Kingdom and European Union to expand global first-in-human ASCEND Phase 1/2 clinical trial of CMP-002 in patients with SYNGAP1-related disorder, adding to clearances in Australia and Argentina Company remains...
Celcuity Inc. Reports Third Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire, Inc.
REVTORPYK became commercially available on September 30th for the treatment of patients with HR+/HER2- PIK3CA wild-type locally advanced or metastatic breast cancer 91% of U.S. commercial and Medicare lives are in health plans that cover REVTORPYK...
Morales Beverage Group Signs LOI to Acquire Green Light Distribution, Expanding Its Leading Position in Texas & Florida
EIN Presswire
Proposed acquisition strengthens MBG’s market leadership, expanding its brand portfolio, customer reach, and distribution density across Texas and Florida.
Korro Reports Third Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire, Inc.
Started dosing healthy volunteers with KRRO-121 in the Phase 1/2 clinical trial (ANCHOR) Expect to dose participants with Urea Cycle Disorders (UCDs) in the first half of 2027 Anticipate reporting interim data in the second half of 2027 Achieved...
Agios Reports Third Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire, Inc.
Mitapivat (PYRUKYND® and AQVESME®) delivered worldwide net revenues of $55.4 million in third quarter of 2026, more than four times the $12.9 million reported in third quarter of 2025 Strong U.S. demand for AQVESME in thalassemia continues, with...
Goliath Reports 14.61 g/t AuEq Over 6.00 Meters And 11.88 g/t AuEq Over 4 Meters Within Surebet Zone’s High-Grade Core Further Demonstrating Its Continuity And Predictability, Golddigger Property, Golden Triangle, B.C.
GlobeNewswire, Inc.
Assay results confirm grade continuity within the high-grade core of the Surebet Zone, this demonstrates the predictability of the mineralization model with these multiple infill holes reported that will contribute to the planned future maiden...
Beyond Meat® Reports Third Quarter 2026 Financial Results
GlobeNewswire, Inc.
EL SEGUNDO, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ: BYND), otherwise known as Beyond The Plant Protein Company™ (the “Company” or “Beyond Meat”), today reported financial results for its third quarter ended September...
GENFIT Reports Third Quarter 2026 Financial Information and Provides Corporate Update
GlobeNewswire, Inc.
Cash and cash equivalents of €95.6 million as of September 30, 2026; expected to fund the Company beyond 2028, with continued revenue growth and disciplined spending thereafter expected to drive GENFIT toward profitability €36.3 million in revenue...
Monetary Policy Report - November 2026
Bank of England
1.1: Inflation CPI inflation rose to 3.5% in September, with the direct effects of higher energy prices accounting for much of the increase since June. CPI inflation has risen from 2.6% in June to 3.5% in September (Chart 1.1), partly owing to...
Cronos Group Reports 2026 Third Quarter Results
GlobeNewswire, Inc.
Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q3 2026 increased by 73% year-over-year on an organic, constant-currency basis Generated record net revenue in Canada, with...
New report: Small EU rule change could unlock 9.3 billion euros in investments for circular phosphorus production
GlobeNewswire, Inc.
STOCKHOLM, Nov. 05, 2026 (GLOBE NEWSWIRE) -- A minor revision of the EU’s animal feed legislation could unlock more than 9.3 billion euros in investments and reduce Europe’s dependence on imported phosphorus from countries like Russia.
SCYNEXIS Reports Third Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire, Inc.
Completed Phase 1 study of SCY-770, a first-in-class, highly selective, oral direct AMPK activator for the treatment of ADPKD; Phase 2 proof-of-concept trial to initiate in Q4 2026 Awarded BARDA contract providing up to approximately $214 million...
ARKO Corp. Reports Third Quarter 2026 Results and Raises Lower End of the Full Year 2026 Adjusted EBITDA Guidance
GlobeNewswire, Inc.
RICHMOND, Va., Nov. 05, 2026 (GLOBE NEWSWIRE) -- ARKO Corp. (Nasdaq: ARKO) (“ARKO” or the “Company”), one of the largest operators of convenience stores in the United States, ranked by store count and one of the largest fuel wholesalers in North...
Cabaletta Bio Reports Third Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire, Inc.
RESET-Myositis® registrational adult topline results anticipated in 2H27 with BLA submission in 1Q28, including Phase 1/2 juvenile dermatomyositis data for potential PRV eligibility and Phase 1/2 adult durability data Immunomodulator-free...
Sign up for:
Food & Beverage Report
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.